Viewing Study NCT00316420


Ignite Creation Date: 2025-12-25 @ 4:08 AM
Ignite Modification Date: 2026-05-10 @ 4:57 PM
Study NCT ID: NCT00316420
Status: COMPLETED
Last Update Posted: 2010-03-08
First Post: 2006-04-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemcitabine and Capecitabine in Patients With Advanced Pancreatic Cancer
Sponsor: Swedish Medical Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: TI027 PG/HK
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Philip Gold, M.D.
Old Organization: Swedish Medical Center, Swedish Cancer Insitute

Collaborators

Collaborators

Name Class View
None INDUSTRY View